Immunocore Selects Genedata to Scale Up Discovery of Novel TCR Therapeutics
Friday, September 13, 2024
BASEL, Switzerland, Sept. 5, 2024 /PRNewswire-PRWeb/ -- Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, announced today that Immunocore (NASDAQ: IMCR), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, will use Genedata's central Scientific Data Management System (SDMS) to scale up discovery of novel TCR therapeutics.
We are pleased that Immunocore has chosen Genedata to digitalize their data management as they work to develop and deliver transformative immunomodulating medicines. Othmar Pfannes, Ph.D., President of GenedataThe Genedata platform, purpose-built for automating R&D workflows for novel therapeutic modalities, offers both structured data management and assay analytics and makes data uniquely accessible for multimodal analysis and AI/ML applications.
"We are pleased that Immunocore has chosen Genedata to digitalize their data management as they work to develop and deliver transformative immunomodulating medicines," said Othmar Pfannes, Ph.D., President of Genedata. "This underlines once more the quality of our software for innovative biotherapeutics."
Immunocore will use Genedata's SDMS to handle and make use of the increasing volume of complex R&D data across Immunocore's modalities and workflows. The Genedata SDMS is built on Genedata Biologics® and Genedata Screener®, designed to maximize data value and streamline processes, leveraging insights to enhance protein engineering and reduce project timelines.
High-quality SDMS is crucial for data integrity, compliance, and accessibility, as well as enhanced decision-making, innovation, and competitive advantage. Genedata continues to demonstrate leadership in providing cutting-edge solutions for scientific data management and supporting biopharmaceutical companies in their quest to deliver life-changing therapies.
About Genedata
Genedata transforms data into intelligence with innovative software solutions that incorporate extensive biopharma R&D domain knowledge. Multinational biopharmaceutical organizations and cutting-edge biotechs around the globe rely on Genedata to digitalize and automate data-rich and complex R&D processes. From early discovery all the way to the clinic, Genedata solutions help maximize the ROI in R&D expenditure. Founded in 1997, Genedata is headquartered in Basel, Switzerland with additional offices in Boston, London, Munich, San Francisco, Singapore, and Tokyo.
http://www.genedata.com
LinkedIn | X (Twitter) | YouTube
Contact
Allison Kurz
Genedata
Public Relations
pr@genedata.com
Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
All product and service names mentioned are the trademarks of their respective companies.
View original content to download multimedia:https://www.prweb.com/releases/immunocore-selects-genedata-to-scale-up-discovery-of-novel-tcr-therapeutics-302236565.html
SOURCE Genedata
|
|
|
|
|
 |
Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
|
|
Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
|
|
DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
|
|
Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
|
|
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
|
|
Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
|
|
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
|
|
Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
|
|
Genpact Named a Leader in ISG Provider Lens(TM) 2025 for Insurance GCCs and Agentic AI Services | Jan 22, 2026
|
|
Buyers Edge Platform Appoints Jaime Selga to Lead Expansion Across the Middle East, Africa & Asia | Jan 22, 2026
|
|
|
